Dr. Patrick Kevin Lee, MD

Dr. Lee practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Lee's NPI, 1679566335, was assigned on August 29, 2005. Dr. Lee graduated from Keck School of Medicine of USC in 1991. Dr. Lee holds California license G74804.

Dr. Lee's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Lee's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Dermatology Services. Dmand AI also links Dr. Lee to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Lee is board certified in dermatology by the American Board of Dermatology. Dr. Lee is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and minor head injury among the conditions Dr. Lee treats.

CMS data shows 2,647 Medicare services from Dr. Lee across 24 procedure codes in 2024, for 629 Medicare patients. Medicare paid $309,594 for them. Every service was in an office.

CMS counts 629 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 270 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 60, with 51% women.

In 2024, Dr. Lee wrote 438 Medicare Part D claims for 198 patients. 91% of them were for generic drugs. CMS names the drug for 307 of them, across 8 drugs with 11 or more claims each, at $7,960 in total drug cost. In 2023, CMS named 289 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of melanoma (skin cancer) excision by Dr. Lee, more than 91% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Lee, published from 2018 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Dermatology, Mohs Surgery and Skin Neoplasms. Dr. Lee has published most often in Dermatol Surg. Dr. Lee's most frequent co-authors are Dong Kim, MD, Ashley N. Elsensohn, MD and Christopher Bransby Zachary, MD.

CMS Open Payments shows 10 general payments to Dr. Lee from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $150.

Dmand AI lists 2 awards for Dr. Lee.

Dr. Lee graduated from Keck School of Medicine of USC in 1991. Dr. Lee is a member of AAD and ASDS.

Dr. Lee is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.